Literature DB >> 15742120

From scleredema to AL amyloidosis: disease progression or coincidence? Review of the literature.

Magdalena Dziadzio1, Constantinos P Anastassiades, Philip N Hawkins, Michael Potter, Armando Gabrielli, Geraldine M Brough, Carol M Black, Christopher P Denton.   

Abstract

Scleredema (also called scleredema of Buschke) is a fibromucinous connective tissue disorder of unknown cause that belongs to a group of scleroderma-like disorders. We report the case of a 64-year-old lady with long-standing scleredema, associated with a paraprotein, and progressing to multiple myeloma and AL amyloidosis. The relationship of scleredema with paraprotein and multiple myeloma is well established, but only two cases of scleredema associated with amyloidosis have been reported to date. We suggest that amyloidosis may be underdiagnosed in patients with scleredema and paraproteinaemia. Features attributed to extracutaneous manifestations of scleredema could represent systemic amyloidosis. We review published reports of scleredema associated with paraprotein and discuss the difficulties in the differential diagnosis of scleroderma-like disorders. We discuss the diagnosis of plasma cell dyscrasias and amyloidosis and their relevance in rheumatology practice.

Entities:  

Mesh:

Year:  2005        PMID: 15742120     DOI: 10.1007/s10067-004-1076-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  43 in total

1.  Treatment with chemotherapy of scleredema associated with Ig A myeloma.

Authors:  J Santos-Juanes; C G Osuna; J R Iglesias; J F De Quiros; J S del Río
Journal:  Int J Dermatol       Date:  2001-11       Impact factor: 2.736

Review 2.  Diagnostic tools for amyloidosis.

Authors:  Eric Hachulla; Gilles Grateau
Journal:  Joint Bone Spine       Date:  2002-12       Impact factor: 4.929

Review 3.  Scleredema adultorum associated with IgG-kappa multiple myeloma--a case report and review of the literature.

Authors:  E Hodak; R Tamir; M David; M Hart; M Sandbank; A Pick
Journal:  Clin Exp Dermatol       Date:  1988-07       Impact factor: 3.470

4.  Systemic involvement in scleredema of Buschke associated with IgG-kappa paraproteinaemia.

Authors:  T Basarab; N P Burrows; S E Munn; R Russell Jones
Journal:  Br J Dermatol       Date:  1997-06       Impact factor: 9.302

5.  Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis.

Authors:  G I Stables; P C Taylor; A S Highet
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

6.  Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.

Authors:  P L Jager; B P Hazenberg; E J Franssen; P C Limburg; M H van Rijswijk; D A Piers
Journal:  J Nucl Med       Date:  1998-04       Impact factor: 10.057

Review 7.  [Scleredema adultorum Buschke. Case report and review of the literature].

Authors:  A Ulmer; G Schaumburg-Lever; J Bauer; I Kötter; G Fierlbeck
Journal:  Hautarzt       Date:  1998-01       Impact factor: 0.751

8.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

9.  Diagnostic value of bone marrow biopsy in patients with renal disease secondary to familial Mediterranean fever.

Authors:  C Sungur; A Sungur; S Ruacan; N Arik; U Yasavul; C Turgan; S Caglar
Journal:  Kidney Int       Date:  1993-10       Impact factor: 10.612

10.  [Systemic Buschke's scleredema with cardiomyopathy, monoclonal IgG kappa gammopathy and amyloidosis. Case report with autopsy].

Authors:  R A Paz; R E Badra; H M Martí; M J Maxit
Journal:  Medicina (B Aires)       Date:  1998       Impact factor: 0.653

View more
  4 in total

1.  Scleroderma Mimickers.

Authors:  Nadia D Morgan; Laura K Hummers
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-02-05

Review 2.  [Scleredema adultorum : Clinical presentation, diagnostic workup, differential diagnosis, treatment option].

Authors:  A Kreuter
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  Therapy resistant idiopathic scleredema: an underlying pathology not always present.

Authors:  Melike Kalfa; Hayriye Koçanaoğulları; Figen Yargucu Zihni; Gonca Karabulut; Hakan Emmungil; Vedat İnal
Journal:  Eur J Rheumatol       Date:  2015-05-20

Review 4.  Scleroderma mimics.

Authors:  Jennifer Nashel; Virginia Steen
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.